500 N Anaheim Blvd, Anaheim, CA 92805 7145029022 (Phone), 7149992450 (Fax)
CLINICA MI PUEBLO 5835 N Figueroa St, Los Angeles, CA 90042 3232588600 (Phone), 3232588610 (Fax)
9360 Telegraph Rd, Downey, CA 90240 5628690180 (Phone), 5628690984 (Fax)
ABUNDANT LF ADOLESCENT GROWTH 6055 E Washington Blvd Suite 240, Los Angeles, CA 90040 3237228950 (Phone)
RITA MEDICAL CLINIC 2649 E Gage Ave, Huntington Park, CA 90255 3235889367 (Phone), 3235889366 (Fax)
345 S A St, Oxnard, CA 93030 8054834700 (Phone), 8054834711 (Fax)
Certifications:
Internal Medicine, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School University of Illinois At Chicago / College of Medicine Graduated: 1985 Medical School Los Angeles County-U S C Medical Center Graduated: 1985 Medical School Cottage Hosp Graduated: 1985
Products Liability Insurance Coverages Automobile Professional Malpractice
ISLN:
905253549
Admitted:
1985, Missouri 1986, Illinois 1985, U.S. District Court, Eastern District of Missouri 1987, U.S. Court of Appeals, Eighth Circuit 1989, U.S. Supreme Court 1990, U.S. District Court, Southern District of Illinois 1991, U.S. District Court, Western District of Missouri 2003, U.S. Court of Appeals, Seventh Circuit
University:
Marquette University, Milwaukee, WI, B.S., 1982
Law School:
St. Louis University School of Law, J.D., cum laude, 1985
Links:
Site
Biography:
Recognized by: Super Lawyers <br /><br />Practice Description: <br /><br />Mr. Magee focuses his practice on trials involving complex litigation matters, including: <br /><br />· Products liabili...
Thomas R. Magee - Cypress CA, US Monica G. Ferrini - Redondo Beach CA, US Jacob Rajfer - Rolling Hills Estate CA, US
Assignee:
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center - Torrance CA
International Classification:
A61K 48/00
US Classification:
514 44, 536 245, 536 2431, 536 241
Abstract:
A method comprising inhibiting myostatin expression or activity to increase muscle mass. Still further, methods for locally inhibiting myostatin expression or activity to reduce fibrosis are provided. The method comprises introducing a nucleotide sequence into a vector wherein the nucleotide sequence is expressed as a shRNA having a property to inhibit myostatin expression. The vector including the sequence may be delivered to a mammalian tissue. An electrical pulse may be applied across a point of delivery. A composition comprising a vector having a nucleotide sequence wherein the nucleotide sequence is expressed as a shRNA having a property to inhibit myostatin expression is further provided.
New Orleans, LAAssistant Professor at Xavier University of Louisi... Past: Assistant Professor at Mississippi State University, Postdoctoral Fellow at National...